The global Oncology Radiopharmaceuticals Market is estimated to be valued at US$ 3,462.8 million in 2022 and is expected to exhibit a CAGR of 6.0% over the forecast period 2021-2028, as highlighted in a new report published by Coherent Market Insights.Market Overview:The Oncology Radiopharmaceuticals Market is a specialized segment of the pharmaceutical industry that focuses on the development...
SWOT Analysis
Strength: The oncology radiopharmaceuticals market experiences strong growth due to the rising preference for precision medicine and targeted radiotherapy among oncologists. Radiopharmaceuticals help diagnose and treat cancer more accurately. The market witnesses numerous product approvals and launches each year to fulfill the increasing demand. Weakness: High costs associated...
Oncology radiopharmaceuticals are pharmaceuticals used for targeted radiation therapy and diagnosis of cancer and other medical conditions. They consist of a radioisotope attached to a biomolecule or small organic molecule that preferentially binds to targeted tissues. The radioisotope then provides signals that can be detected by medical imaging equipment or releases radiation directly to...